
X
Merck builds in CNS diseases with $576m Calporta buy
https://pharmaphorum.com/news/merck-builds-in-cns-diseases-with-576m-calporta-buy/
Pain Therapeutics Conference
Big pharma will continue developing tanezumab painkiller with Lilly
Improving targeted treatments and partnering on initiatives to reduce stigma and support mental health patients.
Takeda joins with venture capital group to fund neuroscience research